Gsk (GSK) Return on Equity [ROE] (2009 - 2026)
Gsk (GSK) reported Return on Equity [ROE] of 15.35% for the quarter ended Jun 30, 2026, down 16.55 percentage points from 31.89% a year earlier and down 12.39 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk posted Return on Equity [ROE] of 43.91%, up 20.80 percentage points from the prior year.
- Return on Equity [ROE] has a five-year change of +11.21 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Equity [ROE] came in at 23.11% in the year ended Dec 31, 2024 (-23.37 pp), 46.48% in the year ended Dec 31, 2023 (-45.89 pp), 92.37% in the year ended Dec 31, 2022 (+67.37 pp) and 25.00% in the year ended Dec 31, 2021 (-7.70 pp).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Return on Equity [ROE] in data going back to the quarter ended Mar 31, 2009.
- Year over year, Return on Equity [ROE] gained in two of the last eight quarters, with an average year-over-year change of -15.85 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was the quarter ended Dec 31, 2022 (a gain of 259.97 percentage points); the low point was the quarter ended Dec 31, 2023 (a drop of 242.44 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 27.74% (quarter ended Mar 31, 2026), 28.03% (quarter ended Dec 31, 2025) and 46.77% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | - |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 4.97% |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 19.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.92% |
| Mar 31, 2026 | 32.50% |
| Dec 31, 2025 | 33.04% |
| Sep 30, 2025 | 50.51% |
| Jun 30, 2025 | 36.04% |
| Mar 31, 2025 | 34.36% |
| Dec 31, 2024 | 29.05% |
| Sep 30, 2024 | 23.38% |
| Jun 30, 2024 | 34.75% |
| Mar 31, 2024 | 36.69% |
| Dec 31, 2023 | 41.45% |
| Sep 30, 2023 | 130.29% |
| Jun 30, 2023 | 215.15% |
| Mar 31, 2023 | 235.08% |
| Dec 31, 2022 | 280.42% |
| Sep 30, 2022 | 93.05% |
| Jun 30, 2022 | 22.17% |
| Mar 31, 2022 | 25.30% |
| Dec 31, 2021 | 23.92% |
| Sep 30, 2021 | 17.45% |
API Access
Gsk Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();